This 'Venture Creator' Helped Launch Moderna. Now He's Harnessing AI to Find New Drugs. -- Barron's

Barron'sAug 3 00:03 ET

What Makes Tempus AI (TEM) an Attractive Investment?

Yahoo FinanceAug 2 09:55 ET

Tempus Next Launches New Algorithm to Close Care Gaps in Guideline-Directed IHC Testing, Starting With HER2

BusinesswireAug 1 08:30 ET

TD Cowen Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $50

Moomoo NewsAug 1 06:33 ET · Ratings

Maintained Buy Rating for Tempus AI, Inc. Class A Amid Inconsequential Financial Adjustments

TipRanksAug 1 06:26 ET · Ratings

Tempus AI, Remix Therapeutics Expand Data, Sequencing Collaboration

MT NewswiresJul 30 15:57 ET